Beyond First Line Therapy Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer LEARN MORE
Immunotherapy A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients with Locally Advanced, Recurrent, or Metastatic Biliary Tract Cancers LEARN MORE
Beyond First Line Therapy A Phase II Trial of Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer LEARN MORE
Beyond First Line Therapy Safety and Tolerability of TNG462 in Patients with MTAP-deleted Solid Tumors LEARN MORE
